Advertisement
Canada markets open in 3 hours 3 minutes

  • S&P/TSX

    21,708.44
    +52.39 (+0.24%)
     

  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     

  • DOW

    37,775.38
    +22.07 (+0.06%)
     

  • CAD/USD

    0.7261
    -0.0002 (-0.03%)
     

  • CRUDE OIL

    82.30
    -0.43 (-0.52%)
     

  • Bitcoin CAD

    89,331.64
    +4,526.78 (+5.34%)
     

  • CMC Crypto 200

    1,333.31
    +20.68 (+1.60%)
     

  • GOLD FUTURES

    2,395.80
    -2.20 (-0.09%)
     

  • RUSSELL 2000

    1,942.96
    -4.99 (-0.26%)
     

  • 10-Yr Bond

    4.6470
    0.0000 (0.00%)
     

  • NASDAQ futures

    17,439.25
    -108.00 (-0.62%)
     

  • VOLATILITY

    19.07
    +1.07 (+5.94%)
     

  • FTSE

    7,839.59
    -37.46 (-0.48%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • CAD/EUR

    0.6815
    -0.0006 (-0.09%)
     

Germany has only a few hundred doses of remdesivir - health minister

Reuters
Updated ·1 min read

BRUSSELS, July 6 (Reuters) - Germany has only a few hundred doses of COVID-19 antiviral remdesivir, the country's health minister Jens Spahn told European Union lawmakers on Monday, urging to move production of the drug to Europe.

"We do not have a huge inventory now, (it's) a few hundred doses that we have," he said at a video-conference hearing organised by the European Parliament.

Spahn said he was working to ensure the drug could be produced in Europe. Its manufacturer Gilead Sciences Inc has no production facilities for remdesivir in Europe. (Reporting by Francesco Guarascio @fraguarascio and Philip Blenkinsop)